Page last updated: 2024-08-24

carbenoxolone sodium and Allergic Encephalomyelitis

carbenoxolone sodium has been researched along with Allergic Encephalomyelitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, Y; Hu, X; Hu, Z; Li, R; Qiu, W; Zhou, Z1
Doi, Y; Harada, Y; Hua, L; Kawanokuchi, J; Liang, J; Mizuno, T; Noda, M; Shijie, J; Sonobe, Y; Suzumura, A; Takeuchi, H; Yasuoka, S; Yawata, I; Zhou, Y1
Di, M; Endong, L; Hua, L; Kawanokuchi, J; Mizuno, T; Shijie, J; Sonobe, Y; Suzumura, A1
Nevin, RL1

Other Studies

4 other study(ies) available for carbenoxolone sodium and Allergic Encephalomyelitis

ArticleYear
The Effects of Carbenoxolone against Experimental Autoimmune Encephalomyelitis in a Mouse Model.
    Neuroimmunomodulation, 2020, Volume: 27, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Carbenoxolone; Cerebral Cortex; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Random Allocation

2020
Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice.
    The Tohoku journal of experimental medicine, 2009, Volume: 217, Issue:2

    Topics: Animals; Carbenoxolone; Cell Death; Diazooxonorleucine; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Gap Junctions; Glutamic Acid; Glutaminase; Mice; Mice, Inbred C57BL; Microglia; Neurons; Spinal Cord

2009
The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells.
    Journal of neuroimmunology, 2011, Dec-15, Volume: 240-241

    Topics: Animals; Anti-Ulcer Agents; Antigen-Presenting Cells; Carbenoxolone; Cell Differentiation; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Gap Junctions; Interleukin-23; Mice; Mice, Inbred C57BL; Th17 Cells; Up-Regulation

2011
Investigating channel blockers for the treatment of multiple sclerosis: considerations with mefloquine and carbenoxolone.
    Journal of neuroimmunology, 2012, Feb-29, Volume: 243, Issue:1-2

    Topics: Animals; Anti-Ulcer Agents; Antigen-Presenting Cells; Carbenoxolone; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Gap Junctions; Interleukin-23; Th17 Cells

2012